The companies will combine efforts in medical and pharmaceutical technology including robotics and instrumentation as part of a long-term agreement. TU Lankide. Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the production of plasma-derived medicines, and Mondragon, a worldwide leader in work cooperation and one of Spainâ€™s most relevant business groups, today announced an agreement to jointly develop healthcare sector-related...
Home » Posts made in September, 2019
- Grifols and Mondragon sign technology collaboration agreement 6 September, 2019
- Polymers & Medical Applications 2019 10 May, 2019
- Precision Medicine. “Sized medicine” 12 March, 2019
- AULA ONDOAN 2018. AMBIENTES CONTROLADOS 9 November, 2018
- Jornada ‘Retos de la Comunidad AutÃ³noma Vasca en tecnologÃa e innovaciÃ³n’ 24 October, 2018